Restricted accessResearch articleFirst published online 2024-01
Implementation of Quality by Design Approaches for Development and Validation of Reverse-Phase High-Performance Liquid Chromatography Assay Method for Determination of Glycyrrhizin in Nanoformulation
Glycyrrhizin (GL) is the principal constituent of Glycyrrhiza glabra, having antiallergic, anticancer, anti-inflammatory, and antimicrobial action. The reverse-phase high-performance liquid chromatography (RP-HPLC) analytical method was used to quantitatively estimate GL in a nanoformulation and validated as per International Conference on Harmonization Q2 (R1) standards. A stationary phase of the C18-HL reversed-phase column and a mobile phase of acetonitrile and water were used for effective elution. The chromatographic conditions of RP-HPLC were optimized utilizing a quality-by-design approach to accomplish the required chromatographic separation of GL from its nanoformulation with minimal experimental runs. Optimized RP-HPLC conditions for the assay method consist of acetonitrile (41%) and water, pH 1.8, balanced with phosphoric acid (0.1%) as a mobile phase with a flow rate of 1 mL/min. The retention time was found at 7.25 min, and method validation confirmed its sensitivity, preciseness, accuracy, and robustness.
Get full access to this article
View all access options for this article.
References
1.
NikoleliG, NikolelisDP. Low calorie nonnutritive sweeteners. In: Sweeteners Nutritional Aspects, Applications, and Production Technology. (VarzakasT, LabropoulosA, AnestisS, eds.) CRC Press: Victoria University, Footscray Park Campus, Australia; 2012; pp. 79–118.
2.
KaurR, KaurH, DhindsaAS. Glycyrrhiza glabra: A phytopharmacological review. Int J Pharm Sci Res, 2013; 4(7):2470; doi: 10.1304/0/IJPSR.0975-8232.4(7).2470-77
3.
BanerjeeS, BaidyaSK, AdhikariN, et al.Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences. J Mol Struct, 2023; 1275:134642; doi: 10.1016/j.molstruc.2022.134642
4.
ShamsaF, OhtsukiK, HasanzadehE, et al.The anti-inflammatory and anti-viral effects of an ethnic medicine: Glycyrrhizin. J Med Plants, 2010; 9(33):1–28; doi: 20.1001.1.2717204.2010.9.33.19.5
5.
Van RossumT, VultoA, De ManR, et al.Glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther, 1998; 12(3):199–205; doi: 10.1046/j.1365-2036.1998.00309.x
6.
HanS, SunL, HeF, et al.Anti-allergic activity of glycyrrhizic acid on IgE-mediated allergic reaction by regulation of allergy-related immune cells. Sci Rep, 2017; 7(1):7222; doi: 10.1038/s41598-017-07833-1
7.
FuY, ZhouE, WeiZ, et al.Glycyrrhizin inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model. FEBS J, 2014; 281(11):2543–2557; doi: 10.1111/febs.12801
8.
SuiX, WeiW, YangL, et al.Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process. Int J Pharm, 2012; 423(2):471–479; doi: 10.1016/j.ijpharm.2011.12.007
9.
BernelaM, AhujaM, ThakurR. Enhancement of anti-inflammatory activity of glycyrrhizic acid by encapsulation in chitosan-katira gum nanoparticles. Eur J Pharm Biopharm, 2016; 105:141–147; doi: 10.1016/j.ejpb.2016.06.003
10.
SelyutinaOY, PolyakovN. Glycyrrhizic acid as a multifunctional drug carrier—From physicochemical properties to biomedical applications: A modern insight on the ancient drug. Int J Pharm, 2019; 559:271–279; doi: 10.1016/j.ijpharm.2019.01.047
MorieA, GargT, GoyalAK, et al.Nanofibers as novel drug carrier—An overview. Artif Cells Nanomed Biotechnol, 2016; 44(1):135–143; doi: 10.3109/21691401.2014.927879
13.
SharmaR, SinghH, JoshiM, et al.Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst, 2014; 31(3):187–217; doi: 10.1615/CritRevTherDrugCarrierSyst.2014008193
14.
MalikR, GargT, GoyalAK, et al.Diacerein-loaded novel gastroretentive nanofiber system using PLLA: Development and in vitro characterization. Artif Cells Nanomed Biotechnol, 2016; 44(3):928–936; doi: 10.3109/21691401.2014.1000492
15.
ShamsaF, SouriE, JalalizadehH, et al.Determination of glycyrrhetic acid in rat plasma by HPLC after oral administration of licorice aqueous extract. Iran J Pharm Sci, 2007; 3(1):51–56; doi: 10.2203/7/ijps.v3.40339
16.
ShiraziZ, PiriK, AslAM, et al.Glycyrrhizin and isoliquiritigenin production by hairy root culture of Glycyrrhiza glabra. Med Plants Res, 2012; 31:4640–4646; doi: 10.5897/JMPR11.1651
17.
ShenS, ChangZ, LiuJ, et al.Simultaneous determination of glycyrrhizic acid and liquiritin in Glycyrrhiza uralensis extract by HPLC with ELSD detection. J Liq Chromatogr Relat Technol, 2006; 29(16):2387–2397; doi: 10.1080/10826070600864858
18.
DeAK, DattaS, MukherjeeA. Quantitative analysis of glycyrrhizic acid from a polyherbal preparation using liquid chromatographic technique. J Adv Pharm Technol Res, 2012; 3(4):210; doi: 10.4103/2231-4040.104711
19.
JitrangsriK, KamataK, AkibaM, et al.Is 18α-glycyrrhizin a real natural product? Improved preparation of 18α-glycyrrhizin from 18β-glycyrrhizin as a positive standard for HPLC analysis of licorice extracts. J Nat Med, 2022; 76(2):367–378; doi: 10.1007/s11418-021-01589-9
20.
BrovchenkoB, ErmakovaV, BokovD, et al.Validation of an HPLC-UV procedure for determining the glycyrrhizic acid content in licorice roots. Pharm Chem J, 2020; 53:1168–1173; doi: 10.1007/s11094-020-02142-w
21.
FukudaIM, PintoCFF, MoreiraCdS, et al.Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD). Braz J Pharm Sci, 2018; 54; doi: 10.1590/s2175-97902018000001006
22.
MurrayPM, BellanyF, BenhamouL, et al.The application of design of experiments (DoE) reaction optimisation and solvent selection in the development of new synthetic chemistry. Org Biomol Chem, 2016; 14(8):2373–2384; doi: 10.1039/C5OB01892G
23.
N. Politis S, Colombo P, Colombo G, et al. Design of experiments (DoE) in pharmaceutical development. Drug Dev Ind Pharm, 2017; 43(6):889–901; doi: 10.1080/03639045.2017.1291672
24.
KarmarkarS, GarberR, GenchanokY, et al.Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. J Chromatogr Sci, 2011; 49(6):439–446; doi: 10.1093/chrsci/49.6.439
25.
BhattDA, RaneSI. QbD approach to analytical RP-HPLC method development and its validation. Int J Pharm Pharm Sci, 2011; 3(1):179–187.
26.
GargNK, SharmaG, SinghB, et al.Quality by design (QbD)-based development and optimization of a simple, robust RP-HPLC method for the estimation of methotrexate. J Liq Chromatogr Relat Technol, 2015; 38(17):1629–1637; doi: 10.1080/10826076.2015.1087409
27.
PatilTS, DeshpandeAS. Development of an innovative quality by design (QbD) based stability-indicating HPLC method and its validation for clofazimine from its bulk and pharmaceutical dosage forms. Chromatographia, 2019; 82(2):579–590; doi: 10.1007/s10337-018-3660-8
28.
OchiMM, AmoabedinyG, RezayatSM, et al.In vitro co-delivery evaluation of novel pegylated nano-liposomal herbal drugs of silibinin and glycyrrhizic acid (nano-phytosome) to hepatocellular carcinoma cells. Cell J, 2016; 18(2):135; doi: 10.2207/4/cellj.2016.4308
29.
HalderJ, RajwarTK, PradhanD, et al.Glycyrrhizin loaded hyaluronic acid nanofiber-based artificial saliva for the management of oral mucositis: Preparation, optimization and in-vitro evaluation. J Drug Delivery Sci Technol, 2023; 87:104777; doi: 10.1016/j.jddst.2023.104777
30.
MunizVM, Chaves JúniorJV, AragãoCFS, et al.A HPLC method for simultaneous quantification of chlorhexidine and thymol using Box-Behnken design for robustness of the method assessment. J Liq Chromatogr Relat Technol, 2023:1–12; doi: 10.1080/10826076.2023.2227792
31.
AroraD, KhuranaB, NarangR, et al.Quality by design (QbD) approach for optimization and development of nano drug delivery systems. Trends Drug Delivery, 2016; 3:23–32; doi: 10.3759/1/tdd.v3i3.296
32.
KhuranaB, AroraD, NarangRK. QbD based exploration of resveratrol loaded polymeric micelles based carbomer gel for topical treatment of plaque psoriasis: In vitro, ex vivo and in vivo studies. J Drug Delivery Sci Technol, 2020; 59:101901; doi: 10.1016/j.jddst.2020.101901
33.
JittaSR, Salwa, KumarL, et al.Development and validation of high-performance liquid chromatography method for the quantification of remdesivir in intravenous dosage form. ASSAY Drug Dev Technol, 2021; 19(8):475–483; doi: 10.1089/adt.2021.074
34.
KumarR, KumarR, KhursheedR, et al.Validated reverse phase-high-performance liquid chromatography method for estimation of fisetin in self-nanoemulsifying drug delivery system. ASSAY Drug Dev Technol, 2020; 18(6):274–281; doi: 10.1089/adt.2020.983
35.
KapoorB, GuptaR, GulatiM, et al.High-performance liquid chromatography and liquid chromatography/mass spectrometry studies on stress degradation behavior of sulfapyridine and development of a validated, specific, stability-indicating HPLC assay method. ASSAY Drug Dev Technol, 2020; 18(3):119–133; doi: 10.1089/adt.2019.959
36.
KsNS, K GP, VermaR, et al.Validation of HPLC method for quantitative determination of gefitinib in polymeric nanoformulation. Pharm Chem J, 2017; 51:159–163; doi: 10.1007/s11094-017-1575-6
37.
BranchSK. Guidelines from the international conference on harmonisation (ICH). J Pharm Biomed Anal, 2005; 38(5):798–805; doi: 10.1016/j.jpba.2005.02.037
